Skip to content
The Great Grantsby G

EIT Health

RIS Country Representatives

2027-2028

Last seen in a scan/import: .

Catalog updated: .

These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.

No deadline is on file for this call. Check EIT Health's own call page for the current round's status before you plan around it.

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

EIT Health funds organisations to act as national representatives for its Regional Innovation Scheme (RIS) in eleven eligible countries across Central, Eastern and Southern Europe, for the 2027-2028 period. Applicants can be a single legal entity or a national consortium spanning at least two sides of the Knowledge Triangle, education, research or industry, and the role involves strengthening the local healthcare innovation ecosystem, supporting innovators and start-ups, and promoting EIT Health programmes in-country.

Details

Funder EIT Health
Duration 2027-2028
Consortium Optional — may apply as a single organisation or a national consortium representing at least two sides of the Knowledge Triangle (education, research, industry), all partners from the same eligible country
Frequency Annual
Eligible countries HRCZEEGRHULVMTRORSSITR

Eligibility & scope

Seeks organisations to act as national representatives strengthening healthcare innovation ecosystems in selected EIT Regional Innovation Scheme countries for 2027-2028, promoting EIT Health programmes and supporting local innovators and start-ups.

Who Should Apply

  • •Legal entities registered in one of the eligible RIS countries (HR, CZ, EE, GR, HU, LV, MT, RO, RS, SI, TR)
  • •Organisations with an established role in healthcare innovation, start-up support, or research-industry engagement
  • •Single applicants or national consortia covering at least two sides of the Knowledge Triangle (education, research, industry)
  • •All consortium partners based in the same eligible country

Key Dates

  • •Representative role covers the 2027-2028 period

Tips for Applicants

  • ✓Clearly map which two (or more) Knowledge Triangle sides your organisation or consortium covers, this is a stated eligibility requirement, not just a preference.
  • ✓Since all partners must be based in the same eligible country, cross-border consortia will not qualify, keep partnerships domestic.
  • ✓Emphasise existing ties to local start-ups and innovators, since ecosystem support and start-up engagement are named parts of the role.

Frequently Asked Questions

Which countries are eligible for the EIT Health RIS Country Representatives call?

Croatia, Czechia, Estonia, Greece, Hungary, Latvia, Malta, Romania, Serbia, Slovenia and Turkey.

Can a single organisation apply, or is a consortium required?

A consortium is optional, a single organisation or a national consortium can apply, as long as at least two sides of the Knowledge Triangle (education, research, industry) are represented.

What does the RIS Country Representative role involve?

It involves strengthening the national healthcare innovation ecosystem, supporting innovators and start-ups, and promoting EIT Health programmes in the country.

How long does the RIS Country Representative role last?

The role covers the 2027-2028 period.

eit-healthregional-innovation-schemehealthcare-innovationconsortium-optionalstart-up-supporteastern-europenational-representative
View full call →
Share ✉ Email X LinkedIn WhatsApp

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Grants for Czech researchers

Could RIS Country Representatives be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →